PackGene is a world-leading adeno-associated virus (AAV) vector CRO and CDMO company founded in 2014. We provide economical, reliable, and scalable plasmid DNA and AAV viral vector production for early-stage drug discovery, preclinical development and clinical trials for Cell and Gene Therapy (CGT). Our proprietary π-Alpha™ 293 AAV High-yield Platform uses uniquely designed RC plasmid in the triple-plasmid transfection system to increase AAV production by 3 to 8 fold. By combining in-process upstream and downstream QbD optimizations we further increase total AAV yield up to 10 fold. A single batch of AAV production at PackGene delivers up to 1E+17vg virus particles – enough to meet most commercial and clinical project requirements.
CRO Services
One-stop Custom AAV Packaging Services
CDMO Services
One-stop CDMO Services for GMP Manufacturing
Technology Platforms
π-Icosa™ AAV Serotype Screening Platform
Projects Delivery
Clients
GMP Facility
What Customers Are Saying About Us
Leading technology and global reputation
Decibel, Principal Scientist
“A lot of our programs internally have been having great results with the AAV8 vectors you all have been packaging. PackGene is rapidly becoming our go-to for AAV8 vectors! ”
Biogen Scientist
“I have spreaded the word of my satisfaction with your AAV vectors to many people in Biogen’s research labs and I hope we continue to be a regular customer in the future.”
